Seminars in Oncology
Volume 32, Issue 2 , Pages 211-218 , April 2005

Psychosocial oncology: Supportive care for the cancer patient

References 

  1. In:  Holland JC ,  Breitbart W ,  Jacobsen PB , et al. editor. Psycho-Oncology . New York, NY: Oxford University Press; 1998;
  2. American Cancer Society . Cancer Facts and Figures—2004 . Atlanta, GA: ACS; 2004;
  3. Holland JC , Kash KM , Passik S , et al.   A brief spiritual beliefs inventory for use in quality of life research in life-threatening illness . Psychooncology . 1998;7:460–469
  4. Flannelly KJ , Weaver AJ , Handzo GF . A three-year study of chaplains’ professional activities at Memorial Sloan-Kettering Cancer Center in New York City . Psychooncology . 2003;12:760–768
  5. Craig TJ , Abeloff MD . Psychiatric symptomatology among hospitalized cancer patients . Am J Psychiatry . 1974;131:1323–1326
  6. Bard M , Sutherland AM . The psychological impact of cancer and its treatment (IV adaptation to radical mastectomy) . Cancer . 1955;8:656–672
  7. Derogatis LR , Morrow GR , Fetting J , et al.   The prevalence of psychiatric disorders among cancer patients . JAMA . 1983;249:751–757
  8. Stefanek ME , Derogatis LP , Shaw A . Psychological distress among oncology outpatients (Prevalence and severity as measured with the Brief Symptom Inventory) . Psychosomatics . 1987;28:530–532
  9. Potash M , Breitbart W . Affective disorders in advanced cancer . Hematol Oncol Clin North Am . 2002;16:671–700
  10. Sharpe M , Strong V , Allen K , et al.   Major depression in outpatients attending a regional cancer centre (Screening and unmet treatment needs) . Br J Cancer . 2004;90:314–320
  11. Holland JC . NCCN Task Force: Practice Guidelines in Oncology—v. 1. 2003 . 2003; www.nccn.org/physician_gls/f_guidelines.html
  12. Morasso G , Costantini M , Baracco G , et al.   Assessing psychological distress in cancer patients (Validation of a self-administered questionnaire) . Oncology . 1996;53:295–302
  13. Cull A , Gould A , House A , et al.   Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice . Br J Cancer . 2001;85:1842–1849
  14. In: Physicians’ Desk Reference (ed 58). Montvale, NJ: Thomson Healthcare; 2004;
  15. Duffy LS , Greenberg DB , Younger J , et al.   Iatrogenic acute estrogen deficiency and psychiatric syndromes in breast cancer patients . Psychosomatics . 1999;40:304–308
  16. Day R , Ganz PA , Costantino JP , et al.   Health-related quality of life and tamoxifen in breast cancer prevention (A report from the National Surgical Adjuvant Breast and Bowel Project P-1 study) . J Clin Oncol . 1999;17:2659–2669
  17. Fallowfield L , Fleissig A , Edwards R , et al.   Tamoxifen for the prevention of breast cancer (Psychosocial impact on women participating in two randomized controlled trials) . J Clin Oncol . 2001;19:1885–1892
  18. Costa D , Mogos I , Toma T . Efficacy and safety of mianserin in the treatment of depression of women with cancer . Acta Psychiatr Scand . 1985;320(suppl):85–92
  19. Holland JC , Roman SJ , Heiligenstein JH , et al.   A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer . Psychooncology . 1998;7:291–300
  20. Pezzella G , Moslinger-Gehmayr R , Contu A . Treatment of depression in patients with breast cancer (A comparison between paroxetine and amitriptyline) . Breast Cancer Res Treat . 2001;70:1–10
  21. Musselman DL , Lawson DH , Gumnick JF , et al.   Paroxetine for the prevention of depression induced by high-dose interferon alfa . N Engl J Med . 2001;344:961–966
  22. Theobald DE , Kirsh KL , Holtsclaw E , et al.   An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms . J Pain Symptom Manage . 2002;23:442–447
  23. Van Gool AR , Bannink M , Stronks DL , et al.   Re (Mirtazapine in cancer patients) . J Pain Symptom Manag . 2003;25:7–8
  24. Morrow GR , Hickok JT , Roscoe JA , et al.   Differential effects of paroxetine on fatigue and depression (A randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program) . J Clin Oncol . 2003;21:4635–4641
  25. Fisch MJ , Loehrer PJ , Kristeller J , et al.   Fluoxetine versus placebo in advanced cancer outpatients (A double-blinded trial of the Hoosier Oncology Group) . J Clin Oncol . 2003;21:1937–1943
  26. Cotterchio M , Kreiger N , Darlington G , et al.   Antidepressant medication use and breast cancer risk . Am J Epidemiol . 2000;151:951–957
  27. Sharpe CR , Collet J-P , Belzille E , et al.   The effects of tricyclic antidepressants on breast cancer risk . Br J Cancer . 2002;86:92–97
  28. Kurdyak PA , Gnam WH , Streiner DL . Antidepressants and the risk of breast cancer . Can J Psychiatry . 2002;47:966–970
  29. Lawlor DA , Juni P , Ebrahim S , et al.   Systematic review of the epidemiologic and trial evidence of an association between antidepressant medication and breast cancer . J Clin Epidemiol . 2003;56:155–163
  30. Bahl S , Cotterchio M , Kreiger N . Use of antidepressant medications and the possible association with breast cancer risk (A review) . Psychother Psychosom . 2003;72:185–194
  31. In:  Cohen S ,  Syme SL editor. Social Support and Health . New York, NY: Academic Press; 1985;
  32. Trunzo JJ , Pinto BM . Social support as a mediator of optimism and distress in breast cancer survivors . J Consult Clin Psychol . 2003;71:805–811
  33. NIH State-of-the-Science Statement on symptom management in cancer (Pain, depression, and fatigue) . NIH Consensus Science Statements . 2002;19:1–29
  34. Worden JW , Weisman AD . Preventive psychosocial intervention with newly diagnosed cancer patients . Gen Hosp Psychiatry . 1984;6:243–249
  35. Greer S , Moorey S , Baruch JD , et al.   Adjuvant psychological therapy for patients with cancer (A prospective randomised trial) . BMJ . 1992;304:675–680
  36. Antoni MH , Lehman JM , Kilbourn KM , et al.   Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer . Health Psychol . 2001;20:20–32
  37. Kissane DW , Bloch S , Smith GC , et al.   Cognitive-existential group psychotherapy for women with primary breast cancer (A randomised controlled trial) . Psychooncology . 2003;12:532–546
  38. Spiegel D , Bloom J , Yalom I . Group support for patients with metastatic cancer (A randomized outcome study) . Arch Gen Psychiatry . 1981;38:527–533
  39. Spiegel D , Bloom JR , Kraemer HC , et al.   Effect of psychosocial treatment on survival of patients with metastatic breast cancer . Lancet . 1989;2:888–891
  40. Goodwin PJ , Leszcz M , Ennis M , et al.   The effect of group psychosocial support on survival in metastatic breast cancer . N Engl J Med . 2001;345:1719–1726
  41. Cunningham AJ , Edmonds CVI , Jenkins GP , et al.   A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer . Psychooncology . 1998;7:508–517
  42. Classen C , Butler LD , Koopman C , et al.   Supportive-expressive group therapy and distress in patients with metastatic breast cancer (A randomized clinical intervention trial) . Arch Gen Psychiatry . 2001;58:494–501
  43. Fawzy FI , Cousins N , Fawzy NW , et al.   A structured psychiatric intervention for cancer patients, I (Changes over time in methods of coping and affective disturbance) . Arch Gen Psychiatry . 1990;47:720–725
  44. Fawzy FI , Fawzy NW , Arndt LA , et al.   Critical review of psychosocial interventions in cancer care . Arch Gen Psychiatry . 1995;52:100–113
  45. Fawzy FI , Canada AL , Fawzy NW . Effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up . Arch Gen Psychiatry . 2003;60:100–103
  46. Kash KM , Holland JC , Halper MS , et al.   Psychological distress and surveillance behaviors of women with a family history of breast cancer . J Natl Cancer Inst . 1992;84:24–30
  47. Lerman C , Kash KM , Stefanek M . Younger women at increased risk for breast cancer (Perceived risk, psychological well-being, and surveillance behavior) . Monogr Natl Cancer Inst . 1994;16:171–176
  48. Kash KM , Holland JC , Osborne MP , et al.   Psychological counseling strategies for women at high risk for breast cancer . Monogr Natl Cancer Inst . 1995;17:73–79
  49. Wellisch DK , Hoffman A , Goldman S , et al.   Depression and anxiety symptoms in women at high risk for breast cancer (Pilot study of a group intervention) . Am J Psychiatry . 1999;156:1644–1645

PII: S0093-7754(04)00567-6

doi: 10.1053/j.seminoncol.2004.11.011

Seminars in Oncology
Volume 32, Issue 2 , Pages 211-218 , April 2005

Article Tools